Filana Therapeutics, Inc. Operating Lease, Expense
Filana Therapeutics, Inc. (FLNA) reported Operating Lease, Expense of $100.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2023-02-28
- Filana Therapeutics, Inc. operating lease, expense for fiscal 2022 was $100.00K, a 0.00% change from fiscal 2021.
- Filana Therapeutics, Inc. operating lease, expense for fiscal 2021 was $100.00K, a 0.00% change from fiscal 2020.
- Filana Therapeutics, Inc. operating lease, expense for fiscal 2020 was $100.00K.
| Period end | Operating Lease, Expense 12 month |
|---|---|
| 2022-12-31 | $100.00K 10-K · filed 2023-02-28 |
| 2021-12-31 | $100.00K 10-K · filed 2023-02-28 |
| 2020-12-31 | $100.00K 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |